Charlie Hospital Semarang Tbk. vs Tunas Alfin Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Tunas Alfin Tbk. trades at Rp610 (market cap 839.13B, 28.3K 24h volume). The key difference: Charlie Hospital Semarang Tbk. and Tunas Alfin Tbk. are close in size by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 28.3K). Which is the better fit depends on your goals.
| RSCH | TALF | |
|---|---|---|
Market Cap | 742B | 839.13B |
Volume | 29.45M | 28.3K |
Lot | 294.49K | 283 |
Turnover | 8.14B | 17.16M |
Average Price | 276.35 | 606.18 |
Value | 8.14B | 17.16M |
Indicative Equilibrium Price | 270 | 610 |
Indicative Equilibrium Volume | 103 | 46 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Tunas Alfin Tbk (the Company) was founded in 1977 and is based in Jakarta, Indonesia. With one of the largest production capacities, and some of the most advanced equipment and technologies in the region, the Company has also grown into one of the leading integrated fine and Fast Moving Consumer Goods (FMCG) packaging companies in Asia.The Company is currently capable of undertaking several coating processes such as Silicone, Hot Melt, Extrusion, Pressure/Self-Adhesive, Wax Coating and Anti-fungus Coating.
Read more on TALF →